Orange Book product · Generic (ANDA)
NANDROLONE DECANOATE
NANDROLONE DECANOATE
At a glance
Dec 05, 1983
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 05, 1983
43 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
NANDROLONE DECANOATE
Strength
200MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 088128
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NANDROLONE DECANOATE
- 1986DECA-DURABOLINBrand (NDA)
NDA 013132 · WOODWARD SPECL
- 2010NANDROLONE DECANOATEGeneric (ANDA)
ANDA 091252 · AM REGENT
- 1986NANDROLONE DECANOATEGeneric (ANDA)
ANDA 088554 · WATSON LABS
- 1984NANDROLONE DECANOATEGeneric (ANDA)
ANDA 086385 · WATSON LABS
- 1984NANDROLONE DECANOATEGeneric (ANDA)
ANDA 086598 · WATSON LABS
- 1983NANDROLONE DECANOATEGeneric (ANDA)
ANDA 088317 · ABRAXIS PHARM
- 1983NANDROLONE DECANOATEGeneric (ANDA)
ANDA 087598 · WATSON LABS
- 1983NANDROLONE DECANOATEGeneric (ANDA)
ANDA 087599 · WATSON LABS
- 1983NANDROLONE DECANOATEGeneric (ANDA)
ANDA 088290 · ABRAXIS PHARM
- 1983NANDROLONE DECANOATEGeneric (ANDA)
ANDA 087519 · EPIC PHARMA LLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
